Kunaprayoon Lalida, Scheffel Emily T C, Abdel-Rahman Emaad M
Division of Nephrology, University of Virginia, Charlottesville, VA 22903, USA.
School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
Biomedicines. 2024 Apr 19;12(4):906. doi: 10.3390/biomedicines12040906.
Nephrotic range proteinuria in the setting of dual-positive anti-glomerular basement membrane (AGBM) and anti-neutrophil cytoplasmic antibodies (ANCAs) is rare. Furthermore, using rituximab as a primary immunosuppressant along with steroids and plasmapheresis has not been widely studied. We present a case of dual AGBM and ANCA with nephrotic range proteinuria in a young female, where rituximab was used as a primary immunosuppressant with partial recovery.
在同时存在抗肾小球基底膜(AGBM)抗体和抗中性粒细胞胞浆抗体(ANCA)阳性的情况下出现肾病范围蛋白尿的情况较为罕见。此外,将利妥昔单抗作为主要免疫抑制剂联合类固醇和血浆置换的应用尚未得到广泛研究。我们报告了一例年轻女性同时患有AGBM和ANCA且伴有肾病范围蛋白尿的病例,该病例中利妥昔单抗被用作主要免疫抑制剂,患者部分恢复。